HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Mecucci Selected Research

Calcium-Transporting ATPases (Ca2+ ATPase)

1/2020Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Mecucci Research Topics

Disease

25Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 05/2002
22Neoplasms (Cancer)
03/2024 - 08/2002
16Leukemia
01/2022 - 05/2005
15Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 08/2002
11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2024 - 05/2007
10Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023 - 02/2002
6Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 08/2002
6Lymphoma (Lymphomas)
01/2022 - 12/2002
5Residual Neoplasm
11/2022 - 08/2005
3Eosinophilia
02/2022 - 06/2021
3Hypereosinophilic Syndrome (Loeffler Endocarditis)
05/2005 - 04/2004
3Infections
12/2003 - 03/2002
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2023 - 05/2005
2Sickle Cell Anemia (Hemoglobin S Disease)
01/2023 - 11/2016
2COVID-19
01/2023 - 12/2022
2Chromosome Aberrations (Chromosome Abnormalities)
02/2022 - 05/2006
2Trisomy (Trisomies)
10/2019 - 03/2002
2Genetic Translocation (Chromosomal Translocation)
01/2016 - 08/2005
1Chromosome Fragility
11/2023
1Anemia
01/2023
1Hemolysis
01/2023
1Disease Resistance
11/2022
1GATA2 Deficiency
01/2022
1Primary Myelofibrosis (Myelosclerosis)
09/2021
1Thyroiditis
12/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Hemoglobinopathies
01/2020
1Monosomy
10/2019
1Iron Overload
11/2017
1Thalassemia
11/2016
1Lymphoid Leukemia
07/2015
1Autoimmune Diseases (Autoimmune Disease)
05/2015
1Gliosarcoma
03/2015
1Malignant Mesothelioma
03/2015
1Sarcoma (Soft Tissue Sarcoma)
03/2015
1Chromosomal Instability (Chromosome Stability)
02/2014

Drug/Important Bio-Agent (IBA)

15NucleophosminIBA
05/2008 - 01/2005
12nuclear pore complex protein 98IBA
01/2022 - 05/2002
8Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2005
7Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
11/2023 - 03/2014
3RNA (Ribonucleic Acid)IBA
10/2020 - 01/2016
3Phosphotransferases (Kinase)IBA
01/2020 - 08/2002
3AntibodiesIBA
01/2019 - 11/2006
3Imatinib Mesylate (Gleevec)FDA Link
10/2009 - 04/2004
2Hemoglobins (Hemoglobin)IBA
01/2023 - 11/2016
2CytokinesIBA
01/2023 - 01/2020
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022 - 06/2021
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
02/2022 - 10/2009
2Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 02/2014
2NucleotidesIBA
01/2020 - 03/2008
2Dacarbazine (DIC)FDA LinkGeneric
10/2019 - 02/2002
2Protein Isoforms (Isoforms)IBA
03/2013 - 03/2006
2Genetic Markers (Genetic Marker)IBA
08/2005 - 05/2005
2Tyrosine (L-Tyrosine)FDA Link
05/2005 - 08/2002
1LipidsIBA
03/2024
1blinatumomabIBA
11/2023
1Oxygen (Dioxygen)IBA
01/2023
1hydroxyethyl methacrylate (HEMA)IBA
12/2022
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2022
1N-acetylpenicillamineIBA
01/2022
1Glycogen Synthase (Synthase I)IBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1Atorvastatin (Lipitor)FDA Link
01/2022
1Cytokine Receptors (Cytokine Receptor)IBA
06/2021
1Immunoglobulin A (IgA)IBA
12/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020
1Interleukin-7 (Interleukin 7)IBA
01/2020
1Calcium-Transporting ATPases (Ca2+ ATPase)IBA
01/2020
1GlucocorticoidsIBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2019
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2019
1venetoclaxIBA
01/2019
1Lenalidomide (CC 5013)FDA Link
07/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1IronIBA
11/2017
1MTOR InhibitorsIBA
01/2016
1Long Noncoding RNAIBA
01/2016
1Untranslated RNA (Noncoding RNA)IBA
01/2016
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2016
1Janus Kinase InhibitorsIBA
10/2015
1AsbestosIBA
03/2015
1Epirubicin (Ellence)FDA LinkGeneric
03/2014
1trioctyl phosphine oxide (TOPO)IBA
03/2014
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
03/2014
1Cyclin D1IBA
02/2014
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
02/2014

Therapy/Procedure

15Therapeutics
03/2024 - 12/2003
5Hematopoietic Stem Cell Transplantation
12/2023 - 05/2005
2Stem Cell Transplantation
12/2023 - 11/2022
2Transplantation
12/2023 - 05/2005
2Aftercare (After-Treatment)
12/2002 - 03/2002
1Donor Selection
12/2023
1Salvage Therapy
11/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2022
1Immunotherapy
11/2022
1Precision Medicine
11/2022
1Consolidation Chemotherapy
11/2022
1Induction Chemotherapy
01/2020
1Drug Therapy (Chemotherapy)
01/2020